Evidence map›Paper›PMID 27227993›Full record

ArticlePloS one2016

Analysis of the In Vivo Turnover of CD4+ T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys.

Alexandra M Ortiz, Diane G Carnathan, Joana Yu, Katherine M Sheehan, Peter Kim, Arnold Reynaldi, Thomas H Vanderford, Nichole R Klatt, Jason M Brenchley, Miles P Davenport and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Alexandra M OrtizYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Diane G CarnathanYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Joana YuYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Katherine M SheehanYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Peter KimComplex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Sydney, 2052, Australia.
Arnold ReynaldiComplex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Sydney, 2052, Australia.
Thomas H VanderfordYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Nichole R KlattLaboratory of Molecular Microbiology, National Institutes of Health, Bethesda, 20892, Maryland, United States of America.
Jason M BrenchleyLaboratory of Molecular Microbiology, National Institutes of Health, Bethesda, 20892, Maryland, United States of America.
Miles P DavenportComplex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Sydney, 2052, Australia.
Guido SilvestriYerkes National Primate Research Center, and Emory Vaccine Center, Emory University, Atlanta, 30322, Georgia, United States of America.
Emory University · USUNSW Sydney · AUNational Institutes of Health · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI JOHNS, MICHAEL M · 1985 to 2011
$114.0M
Mechanisms of Immune Activation and Disease Progression in Animal ModelsZIAAI001029 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BRENCHLEY, JASON · 2009 to 2025
$28.2M
STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYSR37AI066998 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2011 to 2020
$7.7M
NCRR NIH HHS P51 RR000165NIAID NIH HHS R37 AI066998NIH HHS P51 OD010425NIH HHS P51 OD011132
6 · The paper itself

Abstract

Aberrant turnover of memory CD4+ T-cells is central to Acquired Immunodeficiency Syndrome (AIDS) progression. Understanding the relationship between the turnover of CD4+ subsets and immunological homeostasis during simian immunodeficiency virus (SIV) infection in natural hosts may provide insight into mechanisms of immune regulation that may serve as models for therapeutic intervention in Human Immunodeficiency Virus (HIV)-infected persons. Sooty mangabeys (SMs) have naturally evolved with SIV to avoid AIDS progression while maintaining healthy peripheral CD4+ T-cell counts and thus represent a model by which therapeutic interventions for AIDS progression might be elucidated. To assess the relationship between the turnover of CD4+ subsets and immunological homeostasis during SIV infection in non-progressive hosts, we treated 6 SIV-uninfected and 9 SIV-infected SMs with 2'-bromo-5'-deoxyuridine (BrdU) for 14 days and longitudinally assessed CD4+ T-cell subset turnover by polychromatic flow cytometry. We observed that, in SIV-infected SMs, turnover of CD4+ T-cell naïve and central, transitional, and effector memory subsets is comparable to that in uninfected animals. Comparable turnover of CD4+ T-cell subsets irrespective of SIV-infection status likely contributes to the lack of aberrant immune activation and disease progression observed after infection in non-progressive hosts.

Indexed as

AnimalsCD4-Positive T-LymphocytesCercocebus atysDisease ProgressionLymphocyte ActivationSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocyte SubsetsViral Load

Identifiers

PMID27227993
PMCPMC4881966
OpenAlexW2398086398

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.